StockVS

NASDAQ · USD

Dermata Therapeutics, Inc. (DRMAW) Stock Analysis

Dermata Therapeutics, Inc. (DRMAW) is a stock listed on NASDAQ and quoted in US Dollar.

DRMAW

$0.00

−$0.00 (−78.57%)

Last trade August 17, 2026

This is a derivative instrument — a warrant on Dermata Therapeutics, Inc. (DRMA) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View DRMA →

Price History

Hover for the daily close. The dotted line marks the period open.

DRMAW Key Statistics

As of Aug 17, 2026
Trading
Open
$0.02
Previous Close
$0.00
Day's Range
0.00–0.00
Volume
146.06K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.66

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

DRMAW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−96.77%
2025 (partial year)+0.00%

As of August 17, 2026.

About Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Visit website →